Results 131 to 140 of about 825 (170)
Some of the next articles are maybe not open access.

Effect of Blonanserin on the Proliferation and Migration of Glioblastoma Cells

Die Pharmazie, 2023
Glioblastoma is a highly malignant and invasive brain tumor, and there is an urgent need to establish a treatment option that prevents its growth and metastasis. Blonanserin is an antipsychotic drug widely used in the treatment of schizophrenia. It has recently been reported to inhibit the growth of breast cancer cells.
Tsuchiya, N.   +4 more
openaire   +2 more sources

Effects of Alcohol on the Pharmacokinetics of Blonanserin and N-Deethylated Blonanserin in Healthy Chinese Subjects

Journal of Clinical Psychopharmacology, 2018
Abstract Purpose/Background Blonanserin is a novel antipsychotic drug approved for the treatment of schizophrenia in East Asia. The main objective of the present study was to investigate the effect of alcohol on the pharmacokinetic properties of blonanserin and its metabolite N-deethyl blonanserin in healthy Chinese ...
Shuhua, Deng   +11 more
openaire   +2 more sources

Blonanserin HCl salt and its monohydrate

CrystEngComm, 2012
X-Ray crystal structure of the hydrochloride salt of an antipsychotic drug blonanserin (BLN) and characterization of a high temperature polymorph are reported. The crystal structure of BLN HCl monohydrate was determined. All new solid-state forms are characterized by X-ray diffraction, thermal microscopy, ss-NMR, and FT-IR spectroscopy.
D. Maddileti   +3 more
openaire   +1 more source

Neuroleptic Malignant Syndrome Induced by Blonanserin

Journal of Neuropsychiatry, 2011
Case Report A 30-year-old woman with a diagnosis of mental retardation and with profound intellectual impairment (IQ 45) was admitted to a psychiatric hospital for the first time because of insomnia, psychomotor agitation, monologue, and persecutory delusions.
Keiko Ohoyama   +7 more
openaire   +1 more source

[Blonanserin in the treatment of schizophrenia].

Nihon rinsho. Japanese journal of clinical medicine, 2013
Blonanserin was developed in Japan in 2008 as an antipsychotic drug. It has high affinity for dopamine D2/3 and serotonin 5-HT2A receptors, but shows low affinity for adrenergic alpha1, histamine H1, and muscarinic M1 receptors. Several short-term double-blind trials demonstrated that blonanserin was well tolerated and had equal efficacy to haloperidol
Tomomi, Tenjin, Seiya, Miyamoto
openaire   +1 more source

Blonanserin patch for schizophrenia

Schizophrenia Research, 2020
Chittaranjan, Andrade   +3 more
openaire   +2 more sources

Blonanserin

Reactions Weekly, 2023
openaire   +1 more source

Blonanserin

Reactions Weekly, 2014
openaire   +2 more sources

Blonanserin/lorazepam

Reactions Weekly, 2021
openaire   +1 more source

Home - About - Disclaimer - Privacy